[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338408-105":59,"doc-detail-338408-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","sirt3-inhibits-cell-proliferation-of-nonsmall-cell-lung-carcinoma-by-inducing-ros-production","SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production","","Background: Sirtuin 3 (SIRT3) is a mitochondrial regulator of acetylation levels and may act as an oncogene or tumor suppressor in different cancers. This study evaluates SIRT3’s role in nonsmall cell lung carcinoma (NSCLC). Methods: Bioinformatics assessed SIRT3 differential expression and prognosis, followed by lentiviral SIRT3 overexpression. CCK8 and colony formation measured proliferation, flow cytometry quantified ROS, and a Seahorse assay determined oxygen consumption (OCR). Results: SIRT3 was reduced in NSCLC, with low levels linked to poor prognosis. SIRT3 upregulation inhibited proliferation in A549 and SK-MES-1 cells via increased OXPHOS and ROS production. Conclusions: SIRT3 functions as a tumor suppressor by promoting ROS production to restrain NSCLC progression.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sirt3-inhibits-cell-proliferation-of-nonsmall-cell-lung-carcinoma-by-inducing-ros-production/338408/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sirt3-inhibits-cell-proliferation-of-nonsmall-cell-lung-carcinoma-by-inducing-ros-production/338408.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the biological role of SIRT3 examined in this study?","Question",{"text":112,"@type":113},"SIRT3 is described as a mitochondrial matrix protein regulating acetylation of metabolic enzymes, and its role in cancer biology is investigated in NSCLC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the effect of SIRT3 on NSCLC progression evaluated?",{"text":117,"@type":113},"The study used bioinformatics for differential expression and prognosis, then lentiviral overexpression of SIRT3 followed by CCK8 and colony formation assays, ROS detection via flow cytometry, and OCR measurement using a Seahorse assay.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about SIRT3 expression and patient prognosis?",{"text":121,"@type":113},"SIRT3 expression was significantly decreased in NSCLC, and low SIRT3 levels were closely associated with poor prognosis.",{"name":123,"@type":110,"acceptedAnswer":124},"Through what mechanism did SIRT3 suppress NSCLC cell proliferation?",{"text":125,"@type":113},"SIRT3 upregulation suppressed proliferation in A549 and SK-MES-1 cells by increasing oxidative phosphorylation (OXPHOS) and ROS production.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},338408,1790842307,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Clinical Respiratory Journal  \nORIGINAL ARTICLE  OPEN ACCESS   \nSIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production  \nZe Yu1,2  | Hongtao Liao3 | Guanhuai Wu3 | Ying Liu4 | Guoqiang Zhang5 | Liang Xiao6 | Shuibo Yang7 | Jia Liu7,8 | Guocai Yang3  \n1Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Zhejiang University School of Medicine, Zhoushan, Zhejiang, China | 2Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China | 3Department of Cardiothoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China | 4Department of Pharmacy, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China | 5Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang, China | 6Department of Surgery and Oncology, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China | 7School of Agriculture, SUN Yat-Sen  \nUniversity, Shenzhen, Guangdong, China | 8Shenzhen Zhongjia Bio-Medical Technology Co. , LTD, Shenzhen, Guangdong, China Correspondence: Jia Liu ([liujia67@mail.sysu.edu.cn](liujia67@mail.sysu.edu.cn)) | Guocai Yang ([zsygc99@126.com](zsygc99@126.com))  \nReceived: 21 May 2024 | Revised: 15 October 2024 | Accepted: 17 October 2024  \nFunding: This work was supported by the Medical Science and Technology Project of Zhejiang Province (2020RC135) and the Zhejiang Public Welfare Foundation (LGD21H160001) .  \nKeywords: NSCLC | OXPHOS | ROS | SIRT3 | tumor suppressor  \nABSTRACT  \nBackground: Sirtuin 3 (SIRT3) is located in the mitochondrial matrix, regulating acetylation levels of metabolic enzymes. As an oncogene or a tumor suppressor gene, SIRT3 plays an important role in the commencement and progression of certain cancers. In this research, we investigated the role of SIRT3 in the progression of nonsmall cell lung carcinoma (NSCLC) .  \nMethods: In this study, bioinformatics was used to analyze the differential expression of SIRT3 in NSCLC tissue and normal tissues, prognosis, single-cell analysis, and related signaling pathways. The Lentiviral overexpressing SIRT3 was constructed, and CCK8 and colony formation assay were used to evaluate the NSCLC cells proliferation, ROS production was detected by flow cytometry, and the sea-horse test was used to measure cellular oxygen consumption (OCR) .  \nResults: SIRT3 expression was significantly decreased in NSCLC, and low expression of SIRT3 was closely related to the poor prognosis. Besides, on the whole, upregulation of SIRT3 suppressed cell proliferation in A549 and SK-MES-1 cells via increasing oxidative phosphorylation (OXPHOS) and ROS production.  \nConclusions: Overall, our findings suggested that SIRT3 functions as a tumor suppressor that can suppress the progression of NSCLC via stimulating ROS production.  \n1 | Introduction  \nGlobally, lung cancer ranks as the most frequently diagnosed cancer and exhibits the highest cancer-specific mortality rate among both males and females [1] . Annually, around two million fresh instances of lung cancer are detected, leading to 1.7 million new cancer-related fatalities, accounting for 11.6% of  \nall cancer cases and 18.4% of all cancer-related deaths worldwide [2] . Nonsmall cell lung cancer prevails as the predominant form of this malignancy [3] . Given the absence of distinct symptoms, early detection of NSCLC remains unattainable, resulting in the diagnosis of a significant majority of patients at an advanced stage [4] . Chemotherapy agents, particularly cisplatin, are considered the preferred therapeutic approach  \n\n| Ze Yu and Hongtao Liao contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2024 The Author(s) . The Clinical Respiratory Journal pu","cbCaiqHjINmuJdZo","https://ap.wps.com/l/cbCaiqHjINmuJdZo","pdf",10756113,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What is the biological role of SIRT3 examined in this study?\",\"answer\":\"SIRT3 is described as a mitochondrial matrix protein regulating acetylation of metabolic enzymes, and its role in cancer biology is investigated in NSCLC.\"},{\"question\":\"How was the effect of SIRT3 on NSCLC progression evaluated?\",\"answer\":\"The study used bioinformatics for differential expression and prognosis, then lentiviral overexpression of SIRT3 followed by CCK8 and colony formation assays, ROS detection via flow cytometry, and OCR measurement using a Seahorse assay.\"},{\"question\":\"What were the key findings about SIRT3 expression and patient prognosis?\",\"answer\":\"SIRT3 expression was significantly decreased in NSCLC, and low SIRT3 levels were closely associated with poor prognosis.\"},{\"question\":\"Through what mechanism did SIRT3 suppress NSCLC cell proliferation?\",\"answer\":\"SIRT3 upregulation suppressed proliferation in A549 and SK-MES-1 cells by increasing oxidative phosphorylation (OXPHOS) and ROS production.\"}]","SIRT3 Inhibits Cell Proliferation of Nonsmall Cell Lung Carcinoma by Inducing ROS Production | PDF",1790023527,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4285635ab6b5a73910da51204ece525d.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0e7fad7003245cfb1ecf0a136c44b13.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ef6380b87ae8fca49ab7cd8d8bf8cfc.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c0cb8988db6384936188da7a4b60b5e.webp",980,1287]